December 6, 2019

Trial Lawyer Advertising Can Fuel Life Sciences Litigation, Attorneys Say

Two attorneys with the DLA Piper law firm say trial lawyer advertising, combined with lower standards for mass tort lawsuits, can fuel litigation against the life sciences industry.

Saher Valiani and Matthew Holian wrote in Law360 that the rise of social media and big data “litigation frequently precedes — and even precipitates — regulatory scrutiny,” meaning that lawsuits are filed before companies can get legal clarity from government agencies. The “accessibility of real-world data, social media and post-marketing adverse event reporting” makes building massive cases easier “before the FDA can evaluate all the available evidence.”

News In The News-June 11, 2021 Asbestos News Law360 - "Calif. Bar Admits Errors In 40 Years Of Girardi Probes” News In The News-June 9, 2021 Class Action Litigation News Freedom Foundation: Court Loss For Minnesota AG Is A Win For Accountability, Transparency State Attorneys General Blog Australia to Address Low and Disproportionate Returns for Class Action Claimants International Initiatives
We Use Cookies to Make your Experience Better

What do we use cookies for?

We use cookies and similar technologies to recognize your repeat visits and preferences, as well as to measure the effectiveness of campaigns and analyze traffic. To learn more about cookies, including how to disable them, view our Cookie Policy. By clicking "I Accept" or "X" on this banner, or using our site, you consent to the use of cookies unless you have disabled them.